Blue Trust’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2 Buy
+2
New +$3 ﹤0.01% 2517

Other funds holding CHRS

Blue Trust's CHRS Position: Q3 2026 in Review

Blue Trust opened a new position in Coherus Oncology (CHRS) in Q3 2026: 2 shares worth $2. The stake represents ﹤0.01% of the portfolio and ranks #2517 among its holdings.

100 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.

  • Blue Trust held 2 shares of Coherus Oncology worth $2 as of Q3 2026.
  • Coherus Oncology was a new Blue Trust position in Q3 2026.
  • Coherus Oncology made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2517 holding.
  • 100 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.